Gene Expression and Methylation Analysis in Melanomas and Melanocytes From the Same Patient: Loss of NPM2 Expression Is a Potential Immunohistochemical Marker for Melanoma
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2018.00675
Full Text
Open PDFAbstract
Available in full text
Date
January 21, 2019
Authors
Publisher
Frontiers Media SA